. Author manuscript; available in PMC: 2014 Sep 1.

Published in final edited form as: J Int Assoc Provid AIDS Care. 2013 Sep-Oct;12(5):325–333. doi: 10.1177/2325957413491432

Table 6.

Unadjusted and adjusted associations between retinal vasculature measurements and incident reported hypertension or use of hypertensive treatment at baseline, participants without ocular opportunistic infections^*

	Unadjusted		Adjusted^**

	Hazard Ratio	(95% CI)	Hazard Ratio	(95% CI)
Central Retinal Artery Equivalent
1^st vs. 4^th quartile	2.28	(1.63 – 3.21)	2.87	(1.86 – 4.42)
2^nd vs. 4^th quartile	1.53	(1.07 – 2.17)	2.06	(1.36 – 3.13)
3^rd vs. 4^th quartile	1.56	(1.09 – 2.22)	1.73	(1.17 – 2.57)
Central Retinal Vein Equivalent
1^st vs. 4^th quartile	1.11	(0.81 – 1.52)	0.80	(0.53 – 1.21)
2^nd vs. 4^th quartile	0.94	(0.68 – 1.31)	0.83	(0.56 – 1.22)
3^rd vs. 4^th quartile	0.87	(0.62 – 1.21)	0.83	(0.57 – 1.22)

n = 938 participants without ocular opportunistic infection or baseline hypertension and with available retinal vasculature measurements

^**

Adjusted for demographics (age, sex, race, education, insurance status, employment status, weight), HIV characteristics and treatment (HIV risk factor. Time since AIDS diagnosis, CD4+ T-cells: baseline and nadir, HIV viral load: baseline and peak, HAART, PI-based HAART, NNRTI-based HAART) and comorbidities (hyperlipdemia, diabetes and hepatitis C infection: cleared and chronic)